Results 141 to 150 of about 25,852 (227)

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Discrepancy in Estimating GFR for Melphalan Dosing in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplant: A Retrospective Analysis. [PDF]

Kidney360
Teruel B, Golbus AL, Park E, Hashmi H, Murray PT, Davis J, McMahon BA.   +6 more
europepmc   +1 more source

Acral lentiginous melanoma metastases to the vitreous masquerading as uveitis: A case report. [PDF]

Am J Ophthalmol Case Rep
Chahal R, Ahuja P, Al-Zangana R, Arain Z, Chévez-Barrios P, De la Garza Bravo M, Larkin KL, Gombos DS, Chaudhry AL, Al-Zubidi N.   +9 more
europepmc   +1 more source

Melphalan antitumor efficacy and hepatotoxicity: The effect of variable infusion duration in the hepatic artery

, 2003
The optimum conditions (duration and concentration) of a fixed dose, intra-arterial melphalan infusion in relation to its antitumor effect and toxicity in the liver were investigated in a rat colon tumor model (CC531) of liver metastases.
Sparidans, R.W., Velde, C.J.H. van de, Mulder, G.J., Rothbarth, J., Woutersen, R.A.   +4 more
core  

Nutritional Impact of High-Dose Melphalan in Autologous Stem Cell Transplantation. [PDF]

Cureus
El Ouafa Y, Fadi M, Benrahma H, Bouanani N.   +3 more
europepmc   +1 more source

MELPHALAN AS AN IMMUNOMODULATOR IN THE ERADICATION OF ESTABLISHED TUMORS.

, 1985
MELPHALAN AS AN IMMUNOMODULATOR IN THE ERADICATION OF ESTABLISHED ...
ROBERT CHARLES. BOCIAN (7984712)
core  

Melflufen in Multiple Myeloma: Clinical Limitations, Biological Rationale, and Future Perspectives. [PDF]

Cancers (Basel)
Garibotto M, Soncini D, Lemoli RM, Cagnetta A, Cea M.   +4 more
europepmc   +1 more source

D-VRD induction and autologous transplant in patients ≥70 years. [PDF]

Blood Cancer J
Pasvolsky O, Marcoux C, Milton DR, Tanner MR, Islam MB, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Tang G, Aljawai Y, Haider AA, Lee HC, Patel KK, Kebriaei P, Thomas SK, Orlowski RZ, Champlin RE, Shpall EJ, Qazilbash MH.   +21 more
europepmc   +1 more source

Melphalan and urinary estrogens

, 1979
A test of the concept of chemical suppression of ovarian function by cytotoxic drugs previously reported (Anderson et al., 1978, Br. J. Cancer, 37, 477) revealed no supportive evidence from follicular and luteal-phase measurements of plasma oestradiol ...
Grant, J.K., Anderson, J.M., Gettinby, G.   +2 more
core  

Reduced dose versus standard melphalan conditioning for autologous stem cell transplantation in multiple myeloma: a single-center retrospective study. [PDF]

Ann Hematol
Yao Y, Zhang S, Li Z, Luo L, Lu X, Wang H.   +5 more
europepmc   +1 more source